Our Vision
To prevent avoidable blindness from glaucoma
To prevent avoidable blindness from glaucoma through timely diagnosis, evidence-based treatment, patient education, and lifelong follow-up.
Glaucoma is one of the leading causes of irreversible blindness worldwide and is often referred to as the "Silent Thief of Sight" because vision loss occurs gradually and painlessly until advanced stages of the disease. Recognizing the growing burden of glaucoma in India, Drashti Netralaya has established a dedicated Glaucoma Service focused on early detection, accurate diagnosis, advanced treatment, lifelong monitoring, and community awareness.
The Glaucoma Department provides comprehensive care for patients across Gujarat, Rajasthan, and Madhya Pradesh, serving a predominantly rural and tribal population where awareness and access to specialized eye care remain limited.
To prevent avoidable blindness from glaucoma through timely diagnosis, evidence-based treatment, patient education, and lifelong follow-up.
Glaucoma causes progressive damage to the optic nerve, resulting in gradual loss of peripheral vision and eventually blindness if left untreated.
Every patient undergoes a detailed glaucoma assessment using modern diagnostic technology.
Assessment includes:
Measurement of:
Comprehensive examination of:
Accurate measurement of eye pressure is fundamental in glaucoma care.
Considered the international gold standard for measuring intraocular pressure.
Useful for screening large populations and community outreach programs.
Performed when required to detect pressure fluctuations.
Gonioscopy is essential for classifying glaucoma and determining appropriate treatment.
Helps identify patients at risk for acute angle closure and guides laser or surgical intervention.
Detailed evaluation of the optic nerve head is performed using:
Assessment of:
Allows:
Visual field testing is critical for diagnosing and monitoring glaucoma.
High-resolution imaging of:
Assessment of structural damage before visual symptoms appear.
Detection of early glaucomatous damage.
Objective evaluation and follow-up.
Measurement of central corneal thickness.
The majority of glaucoma patients are initially managed with medications.
Special emphasis is placed on:
Laser procedures are offered when clinically indicated.
Used for:
When medications and laser procedures are insufficient to achieve target intraocular pressure or when disease progression continues despite treatment, surgical intervention is recommended.
Drashti Netralaya offers a comprehensive spectrum of glaucoma surgeries tailored to disease severity, patient age, visual status, and individual risk factors.
MIGS represents the latest advancement in glaucoma surgery and is designed to lower intraocular pressure with minimal tissue disruption, faster recovery, and an excellent safety profile.
Drashti Netralaya continuously evaluates and adopts evidence-based MIGS technologies appropriate for patient needs and resource settings.
Trabeculectomy remains the gold-standard filtration surgery for moderate to advanced glaucoma.
Where indicated, antimetabolites such as Mitomycin-C may be utilized to improve long-term surgical success.
For complex and refractory glaucoma, glaucoma drainage implants may be utilized.
Many patients suffer from both cataract and glaucoma.
Reserved for advanced or refractory glaucoma cases.
Dedicated pediatric glaucoma services include:
Preservation of vision and prevention of irreversible visual disability during childhood.
Drashti Netralaya provides specialized surgical care for:
Each patient receives an individualized surgical plan based on disease severity, visual potential, age, and systemic health status.
"The right surgery for the right patient at the right stage of disease."
By combining traditional filtration surgery with modern MIGS technologies, Drashti Netralaya strives to provide safe, effective, and personalized glaucoma care while preserving vision and improving quality of life.
Dedicated services are available for children with glaucoma.
Patients with:
are routinely screened during comprehensive eye examinations.
Recognizing the low awareness of glaucoma in rural communities, Drashti Netralaya conducts regular screening and awareness programmes.
Glaucoma requires lifelong care.
Since 2006, Drashti Netralaya's paperless EMR system has facilitated:
Special emphasis on providing glaucoma care to underserved populations across:
Every glaucoma patient receives:
At Drashti Netralaya, glaucoma care extends beyond controlling eye pressure. Our goal is to preserve vision, maintain quality of life, and prevent irreversible blindness through early detection, advanced technology, patient education, and compassionate lifelong care.